Sign In
Buy DOCS
$21.04
-0.470 (-2.19%)
At Close: Jun 03, 2026
Doximity (DOCS) Upgraded to Buy: What Does It Mean for the Stock?
01:32pm, Friday, 29'th Dec 2023
Doximity (DOCS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
7 Stocks that Multiple AI Bots Predict Will Soar in the Near Future
07:00am, Friday, 29'th Dec 2023
AI stock predictions are all the rage, and for good reason. I asked Google's Bard and ChatGPT to give me some predictions regarding which stocks will soar soon.
The Top Healthcare Stocks to Buy With $100
10:07am, Thursday, 21'st Dec 2023
Pfizer has important, ongoing projects that should start to pay off down the road. Doximity's strong margins, moat, and growth opportunities could mean a bright future.
Future in Fitness: 3 Stocks Innovating in Digital Health
12:03pm, Sunday, 10'th Dec 2023
Digital health and telemedicine are booming sectors offering attractive opportunities to investors looking to capitalize on the growing demand for remote healthcare. A couple of years ago, the Covid-1
5 Telehealth Stocks That Have Nothing But Upside
11:53am, Sunday, 26'th Nov 2023
The telehealth sector is undergoing a significant transformation, reshaping the traditional contours of medical service delivery. This innovation-driven domain is drawing attention from investors, as
Earnings Estimates Moving Higher for Doximity (DOCS): Time to Buy?
01:32pm, Friday, 24'th Nov 2023
Doximity (DOCS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Top 3 Telehealth Stocks to Invest in for a Future of Virtual Care
04:53pm, Tuesday, 14'th Nov 2023
Telehealth stocks were all the rage during the pandemic, with many expecting the valuations of these companies to soar due to people staying home and practicing social distancing. However, as the old
ICLR or DOCS: Which Is the Better Value Stock Right Now?
12:47pm, Friday, 10'th Nov 2023
Investors looking for stocks in the Medical Services sector might want to consider either Icon PLC (ICLR) or Doximity (DOCS). But which of these two stocks offers value investors a better bang for the
Doximity Stock Rallies. Guidance Boost 'Just What the Doctor Ordered.
08:35am, Friday, 10'th Nov 2023
The online platform for medical professionals also reported fiscal second-quarter adjusted earnings that beat analysts' estimates.
Doximity, Inc. (DOCS) Q2 2024 Earnings Call Transcript
11:56pm, Thursday, 09'th Nov 2023
Doximity, Inc. (NYSE:DOCS ) Q2 2024 Earnings Conference Call November 9, 2023 5:00 PM ET Company Participants Perry Gold - VP of IR Jeffrey Tangney - Co-Founder & CEO Anna Bryson - CFO Nate Gross - Co
Doximity (DOCS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
08:18pm, Thursday, 09'th Nov 2023
Although the revenue and EPS for Doximity (DOCS) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall St
Doctors have a new way to scrub personal information from internet after spike in harassment
09:00am, Wednesday, 01'st Nov 2023
Doximity announced a free new service called DocDefender that can remove a physician's personal phone numbers and addresses from public websites
The Top Healthcare Stocks to Buy With $100
09:15am, Saturday, 28'th Oct 2023
Doximity has several things going its way, including its economic moat, high margins, and growth opportunities. Teladoc Health shares continue to fall even as the company has made tremendous progress
MD or DOCS: Which Is the Better Value Stock Right Now?
12:46pm, Tuesday, 03'rd Oct 2023
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Doximity (DOCS). But which of these two stocks presents investors with the better va
1 Growth Stock Down 39% to Buy and Hold for 10 Years
07:15am, Monday, 25'th Sep 2023
Doximity's valuation and slowing sales growth are turning off many investors. Despite these issues, there is a lot to like about the company, including its moat.
